nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—systemic lupus erythematosus	0.797	1	CbGaD
Clenbuterol—ADRB3—connective tissue—systemic lupus erythematosus	0.00096	0.137	CbGeAlD
Clenbuterol—CYP1A2—urine—systemic lupus erythematosus	0.000924	0.132	CbGeAlD
Clenbuterol—NGF—lung—systemic lupus erythematosus	0.00091	0.13	CbGeAlD
Clenbuterol—NGF—nervous system—systemic lupus erythematosus	0.000843	0.12	CbGeAlD
Clenbuterol—NGF—central nervous system—systemic lupus erythematosus	0.000811	0.116	CbGeAlD
Clenbuterol—CYP1A2—blood plasma—systemic lupus erythematosus	0.000482	0.0687	CbGeAlD
Clenbuterol—ADRB1—connective tissue—systemic lupus erythematosus	0.000393	0.056	CbGeAlD
Clenbuterol—ADRB1—lung—systemic lupus erythematosus	0.000237	0.0338	CbGeAlD
Clenbuterol—CYP1A1—skin of body—systemic lupus erythematosus	0.000229	0.0326	CbGeAlD
Clenbuterol—ADRB1—nervous system—systemic lupus erythematosus	0.000219	0.0313	CbGeAlD
Clenbuterol—CYP1A1—kidney—systemic lupus erythematosus	0.000216	0.0307	CbGeAlD
Clenbuterol—ADRB1—central nervous system—systemic lupus erythematosus	0.000211	0.0301	CbGeAlD
Clenbuterol—CYP1A2—lung—systemic lupus erythematosus	0.000155	0.0221	CbGeAlD
Clenbuterol—CYP1A1—lung—systemic lupus erythematosus	0.000153	0.0218	CbGeAlD
Clenbuterol—CYP1A1—nervous system—systemic lupus erythematosus	0.000141	0.0202	CbGeAlD
Clenbuterol—CYP1A1—central nervous system—systemic lupus erythematosus	0.000136	0.0194	CbGeAlD
Clenbuterol—CYP1A2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	9.07e-05	0.000463	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	8.99e-05	0.000459	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	8.99e-05	0.000459	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CXCL12—systemic lupus erythematosus	8.99e-05	0.000459	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—F2—systemic lupus erythematosus	8.9e-05	0.000454	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	8.87e-05	0.000453	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCL12—systemic lupus erythematosus	8.87e-05	0.000453	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCL12—systemic lupus erythematosus	8.79e-05	0.000449	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—TGFB1—systemic lupus erythematosus	8.73e-05	0.000445	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—JUNB—systemic lupus erythematosus	8.71e-05	0.000444	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	8.68e-05	0.000443	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—IL6—systemic lupus erythematosus	8.67e-05	0.000443	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	8.55e-05	0.000437	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	8.48e-05	0.000433	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	8.41e-05	0.000429	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—RXRA—systemic lupus erythematosus	8.35e-05	0.000426	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.27e-05	0.000422	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	8.22e-05	0.000419	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	8.09e-05	0.000413	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	8.07e-05	0.000412	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	8.07e-05	0.000412	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—PRL—systemic lupus erythematosus	8.02e-05	0.000409	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—IL6—systemic lupus erythematosus	7.99e-05	0.000408	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	7.98e-05	0.000407	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CCL2—systemic lupus erythematosus	7.93e-05	0.000405	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	7.91e-05	0.000404	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	7.9e-05	0.000403	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCL12—systemic lupus erythematosus	7.77e-05	0.000396	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	7.76e-05	0.000396	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	7.73e-05	0.000394	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	7.64e-05	0.00039	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	7.55e-05	0.000385	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	7.38e-05	0.000377	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	7.38e-05	0.000377	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	7.25e-05	0.00037	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TGFB1—systemic lupus erythematosus	7.11e-05	0.000363	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL6—systemic lupus erythematosus	7.11e-05	0.000363	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TLR9—systemic lupus erythematosus	7.04e-05	0.000359	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—JAK1—systemic lupus erythematosus	7.02e-05	0.000358	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	7.01e-05	0.000358	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	6.99e-05	0.000357	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	6.94e-05	0.000354	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—P2RY12—systemic lupus erythematosus	6.85e-05	0.00035	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—P2RY12—systemic lupus erythematosus	6.82e-05	0.000348	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	6.8e-05	0.000347	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	6.79e-05	0.000346	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—P2RY12—systemic lupus erythematosus	6.7e-05	0.000342	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—IL6—systemic lupus erythematosus	6.58e-05	0.000336	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	6.55e-05	0.000334	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	6.55e-05	0.000334	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	6.49e-05	0.000331	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	6.44e-05	0.000329	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	6.42e-05	0.000327	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—JAK1—systemic lupus erythematosus	6.42e-05	0.000327	CbGpPWpGaD
Clenbuterol—CYP1A1—PPARA activates gene expression—EP300—systemic lupus erythematosus	6.3e-05	0.000321	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CSK—systemic lupus erythematosus	6.28e-05	0.00032	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—IL6—systemic lupus erythematosus	6.23e-05	0.000318	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—JAK1—systemic lupus erythematosus	6.19e-05	0.000316	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	6.18e-05	0.000316	CbGpPWpGaD
Clenbuterol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	6.17e-05	0.000315	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCR5—systemic lupus erythematosus	6.16e-05	0.000314	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCR5—systemic lupus erythematosus	6.08e-05	0.00031	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	6.05e-05	0.000309	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCR5—systemic lupus erythematosus	6.02e-05	0.000307	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—C3—systemic lupus erythematosus	6.02e-05	0.000307	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.99e-05	0.000306	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—C3—systemic lupus erythematosus	5.94e-05	0.000303	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—C3—systemic lupus erythematosus	5.89e-05	0.0003	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CCR5—systemic lupus erythematosus	5.86e-05	0.000299	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	5.78e-05	0.000295	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NCF2—systemic lupus erythematosus	5.74e-05	0.000293	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—C3—systemic lupus erythematosus	5.73e-05	0.000292	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—LYN—systemic lupus erythematosus	5.7e-05	0.000291	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	5.68e-05	0.00029	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—JAK1—systemic lupus erythematosus	5.62e-05	0.000287	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SH2B3—systemic lupus erythematosus	5.59e-05	0.000285	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCR5—systemic lupus erythematosus	5.32e-05	0.000272	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—F2—systemic lupus erythematosus	5.28e-05	0.00027	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—PPARG—systemic lupus erythematosus	5.27e-05	0.000269	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL2RA—systemic lupus erythematosus	5.25e-05	0.000268	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—F2—systemic lupus erythematosus	5.22e-05	0.000266	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—C3—systemic lupus erythematosus	5.2e-05	0.000266	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—F2—systemic lupus erythematosus	5.17e-05	0.000264	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	5.08e-05	0.000259	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—F2—systemic lupus erythematosus	5.03e-05	0.000257	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CD80—systemic lupus erythematosus	5e-05	0.000255	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	4.97e-05	0.000253	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	4.74e-05	0.000242	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCL2—systemic lupus erythematosus	4.71e-05	0.00024	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCL2—systemic lupus erythematosus	4.65e-05	0.000237	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	4.63e-05	0.000236	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—TYK2—systemic lupus erythematosus	4.62e-05	0.000236	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	4.61e-05	0.000235	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCL2—systemic lupus erythematosus	4.61e-05	0.000235	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL12—systemic lupus erythematosus	4.59e-05	0.000234	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—F2—systemic lupus erythematosus	4.57e-05	0.000233	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL12—systemic lupus erythematosus	4.51e-05	0.00023	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—JUNB—systemic lupus erythematosus	4.5e-05	0.00023	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	4.3e-05	0.000219	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RASGRP1—systemic lupus erythematosus	4.28e-05	0.000218	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	4.25e-05	0.000217	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TYK2—systemic lupus erythematosus	4.22e-05	0.000215	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	4.21e-05	0.000215	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TLR9—systemic lupus erythematosus	4.18e-05	0.000213	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PRL—systemic lupus erythematosus	4.15e-05	0.000212	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NOS3—systemic lupus erythematosus	4.14e-05	0.000211	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.1e-05	0.000209	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TLR9—systemic lupus erythematosus	4.09e-05	0.000209	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCL2—systemic lupus erythematosus	4.07e-05	0.000208	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—P2RY12—systemic lupus erythematosus	4.05e-05	0.000207	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—P2RY12—systemic lupus erythematosus	3.96e-05	0.000202	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	3.82e-05	0.000195	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	3.74e-05	0.000191	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CSK—systemic lupus erythematosus	3.73e-05	0.00019	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.7e-05	0.000189	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	3.67e-05	0.000187	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CSK—systemic lupus erythematosus	3.64e-05	0.000186	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP9—systemic lupus erythematosus	3.64e-05	0.000186	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—JAK1—systemic lupus erythematosus	3.59e-05	0.000183	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.59e-05	0.000183	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL2—systemic lupus erythematosus	3.51e-05	0.000179	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	3.48e-05	0.000178	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—EP300—systemic lupus erythematosus	3.45e-05	0.000176	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	3.43e-05	0.000175	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NCF2—systemic lupus erythematosus	3.41e-05	0.000174	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CCR5—systemic lupus erythematosus	3.4e-05	0.000174	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—C3—systemic lupus erythematosus	3.4e-05	0.000174	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.39e-05	0.000173	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—LYN—systemic lupus erythematosus	3.38e-05	0.000173	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	3.36e-05	0.000171	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—JAK1—systemic lupus erythematosus	3.34e-05	0.00017	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NCF2—systemic lupus erythematosus	3.33e-05	0.00017	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—C3—systemic lupus erythematosus	3.33e-05	0.00017	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MMP9—systemic lupus erythematosus	3.32e-05	0.00017	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SH2B3—systemic lupus erythematosus	3.32e-05	0.000169	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—JAK1—systemic lupus erythematosus	3.32e-05	0.000169	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.31e-05	0.000169	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LYN—systemic lupus erythematosus	3.31e-05	0.000169	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—VEGFA—systemic lupus erythematosus	3.27e-05	0.000167	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—JAK1—systemic lupus erythematosus	3.26e-05	0.000166	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NAT2—systemic lupus erythematosus	3.25e-05	0.000166	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SH2B3—systemic lupus erythematosus	3.25e-05	0.000166	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCR5—systemic lupus erythematosus	3.16e-05	0.000161	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EP300—systemic lupus erythematosus	3.15e-05	0.000161	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCR5—systemic lupus erythematosus	3.15e-05	0.000161	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	3.11e-05	0.000159	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.1e-05	0.000158	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCR5—systemic lupus erythematosus	3.09e-05	0.000158	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—C3—systemic lupus erythematosus	3.09e-05	0.000158	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL2—systemic lupus erythematosus	3.08e-05	0.000157	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—C3—systemic lupus erythematosus	3.07e-05	0.000157	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	3.05e-05	0.000155	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—C3—systemic lupus erythematosus	3.02e-05	0.000154	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—TGFB1—systemic lupus erythematosus	3e-05	0.000153	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—F2—systemic lupus erythematosus	2.99e-05	0.000152	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.99e-05	0.000152	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—F2—systemic lupus erythematosus	2.92e-05	0.000149	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.74e-05	0.00014	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.72e-05	0.000139	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—F2—systemic lupus erythematosus	2.71e-05	0.000138	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—F2—systemic lupus erythematosus	2.7e-05	0.000138	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—JUNB—systemic lupus erythematosus	2.67e-05	0.000136	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.66e-05	0.000136	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—F2—systemic lupus erythematosus	2.65e-05	0.000135	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—JUNB—systemic lupus erythematosus	2.62e-05	0.000133	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.61e-05	0.000133	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CD80—systemic lupus erythematosus	2.59e-05	0.000132	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.59e-05	0.000132	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.54e-05	0.00013	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.49e-05	0.000127	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PRL—systemic lupus erythematosus	2.46e-05	0.000126	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.42e-05	0.000123	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PRL—systemic lupus erythematosus	2.41e-05	0.000123	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCL2—systemic lupus erythematosus	2.41e-05	0.000123	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.36e-05	0.000121	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.33e-05	0.000119	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—IL6—systemic lupus erythematosus	2.26e-05	0.000115	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.19e-05	0.000112	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TYK2—systemic lupus erythematosus	2.18e-05	0.000111	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.15e-05	0.00011	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NOS3—systemic lupus erythematosus	2.14e-05	0.000109	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	2.07e-05	0.000106	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL6—systemic lupus erythematosus	2.06e-05	0.000105	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.03e-05	0.000104	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.01e-05	0.000103	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—JAK1—systemic lupus erythematosus	1.97e-05	0.000101	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.97e-05	0.0001	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—JAK1—systemic lupus erythematosus	1.93e-05	9.83e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCR5—systemic lupus erythematosus	1.87e-05	9.53e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.86e-05	9.48e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.84e-05	9.39e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCR5—systemic lupus erythematosus	1.83e-05	9.32e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL2—systemic lupus erythematosus	1.83e-05	9.32e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—C3—systemic lupus erythematosus	1.82e-05	9.31e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—RXRA—systemic lupus erythematosus	1.82e-05	9.31e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL2—systemic lupus erythematosus	1.82e-05	9.27e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL6—systemic lupus erythematosus	1.81e-05	9.23e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.8e-05	9.18e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL2—systemic lupus erythematosus	1.79e-05	9.12e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—C3—systemic lupus erythematosus	1.78e-05	9.11e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—systemic lupus erythematosus	1.72e-05	8.78e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.71e-05	8.75e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.69e-05	8.63e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.65e-05	8.41e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EP300—systemic lupus erythematosus	1.63e-05	8.32e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—F2—systemic lupus erythematosus	1.6e-05	8.17e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—F2—systemic lupus erythematosus	1.57e-05	8e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.54e-05	7.88e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CD80—systemic lupus erythematosus	1.54e-05	7.84e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CD80—systemic lupus erythematosus	1.5e-05	7.67e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.48e-05	7.57e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.43e-05	7.29e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.42e-05	7.23e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL2—systemic lupus erythematosus	1.4e-05	7.13e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.3e-05	6.62e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.3e-05	6.62e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.27e-05	6.49e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TYK2—systemic lupus erythematosus	1.27e-05	6.47e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NOS3—systemic lupus erythematosus	1.24e-05	6.35e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	1.16e-05	5.93e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PPARG—systemic lupus erythematosus	1.15e-05	5.88e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.1e-05	5.62e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.08e-05	5.5e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL2—systemic lupus erythematosus	1.08e-05	5.5e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.08e-05	5.5e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.07e-05	5.48e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL6—systemic lupus erythematosus	1.07e-05	5.45e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL2—systemic lupus erythematosus	1.06e-05	5.38e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL6—systemic lupus erythematosus	1.05e-05	5.36e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ALB—systemic lupus erythematosus	1.04e-05	5.28e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.02e-05	5.21e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.02e-05	5.19e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—systemic lupus erythematosus	9.99e-06	5.1e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.95e-06	5.08e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NOS3—systemic lupus erythematosus	9.9e-06	5.05e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EP300—systemic lupus erythematosus	9.68e-06	4.94e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EP300—systemic lupus erythematosus	9.47e-06	4.83e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—VEGFA—systemic lupus erythematosus	9.17e-06	4.68e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS2—systemic lupus erythematosus	9.06e-06	4.62e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.97e-06	4.58e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TGFB1—systemic lupus erythematosus	8.41e-06	4.29e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TGFB1—systemic lupus erythematosus	8.23e-06	4.2e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—EP300—systemic lupus erythematosus	7.53e-06	3.84e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	7.34e-06	3.75e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	6.6e-06	3.37e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6—systemic lupus erythematosus	6.34e-06	3.24e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	6.32e-06	3.22e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6—systemic lupus erythematosus	6.2e-06	3.16e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	5.78e-06	2.95e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	4.8e-06	2.45e-05	CbGpPWpGaD
